Lumefantrine API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
Country of origin
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Replies slower than most
Producer
+ 0
All certificates
Not active
Distributor
+ 0
All certificates
Not active
Producer
+ 0
All certificates
Not active
Producer
+ 0
All certificates
Not active
Producer
+ 0
All certificates
Not active
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Lumefantrine API 82186-77-4?
- Description:
- Here you will find a list of producers, manufacturers and traders of Lumefantrine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Lumefantrine
- Synonyms:
- Benflumetol , Lumefantrine
- Cas Number:
- 82186-77-4
- DrugBank number:
- DB06708
- Unique Ingredient Identifier:
- F38R0JR742
About Lumefantrine
Here is a short description about Lumefantrine. Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Lumefantrine is a type of Antimalarial
The Antimalarial category of pharmaceutical APIs encompasses a range of active ingredients used in the development of drugs to treat and prevent malaria, a life-threatening infectious disease caused by the Plasmodium parasite. These APIs are crucial in formulating effective antimalarial medications.
One widely used API in this category is Artemisinin, derived from the Artemisia annua plant. It exhibits potent antimalarial properties and is a key component in various combination therapies. Another prominent API is Chloroquine, an aminoquinoline compound that has been historically used as a primary treatment for malaria. However, due to emerging drug resistance, alternative APIs like Mefloquine and Quinine have gained prominence.
These APIs work by interfering with the life cycle of the Plasmodium parasite. They inhibit various stages of parasite development, such as preventing the replication of the parasite's DNA and disrupting its metabolic processes. By targeting the parasite, antimalarial APIs help to control and eliminate the infection, reducing the severity of symptoms and preventing complications.
The development and production of high-quality antimalarial APIs require stringent quality control measures to ensure their safety and efficacy. Pharmaceutical companies adhere to strict regulations and guidelines to guarantee the purity, stability, and bioavailability of these APIs. Additionally, ongoing research aims to discover new antimalarial APIs and formulations to combat drug resistance and improve treatment outcomes.
In conclusion, the Antimalarial category of pharmaceutical APIs plays a vital role in the formulation of drugs used to treat and prevent malaria. These APIs, such as Artemisinin, Chloroquine, Mefloquine, and Quinine, effectively target the Plasmodium parasite, aiding in the management and eradication of malaria infections.
Lumefantrine manufacturers | traders | suppliers
We have 10 companies offering Lumefantrine produced in 2 different countries.
Get in contact with the supplier of your choice:
- Vital Laboratories Pvt. Ltd. from India, product country of origin India
- Mangalam Drugs & Organics from India, product country of origin India
- Shanghai Desano Chem. from China, product country of origin China
- Aarambh Life Science from India, product country of origin India
- Hangzhou Wenlee from China, product country of origin China
- Cipla from India, product country of origin India
- Shaoxing Hantai Pharma from China, product country of origin China
- Mylan from India, product country of origin India
- Ipca Labs. from India, product country of origin India
- Micro Labs from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
